Perfil
Richard Schoenfeld is Vice President of Operations for PharmAthene, Inc. He joined PharmAthene in October 2005.
He was Vice President of Supply Chain Management for EMD Pharmaceuticals and Senior Vice President of Engineering and Technology Development for Genzyme.
Mr. Schoenfeld held various positions at Endotronics and Monsanto.
He had 30 years of experience in developing and manufacturing proteins.
Mr. Schoenfeld received an Advanced Graduate Certificate in Business Ethics from Bentley College.
He received an MS and a PhD in Bioengineering from the Polytechnic Institute of Brooklyn, a BS in Chemical Engineering from Northeastern University and an MBA from St. Louis University.
Antiguos cargos conocidos de Richard Schoenfeld.
| Empresas | Cargo | Fin |
|---|---|---|
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Director de Operaciones | 09/08/2007 |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - |
Formación de Richard Schoenfeld.
| Northeastern University | Undergraduate Degree |
| St. Louis University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
| Polytechnic University | Consumer Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Schoenfeld
